Your browser doesn't support javascript.
loading
Reproductive Planning: Short-Acting Reversible Contraceptives.
Wilson, Megan L; Godfrey, Emily M; Glass, Samantha; Zhang, Ying.
Affiliation
  • Wilson ML; Department of Family Medicine - University of Washington, Seattle.
  • Godfrey EM; Departments of Family Medicine and Obstetrics and Gynecology - University of Washington, Seattle.
  • Glass S; Department of Family Medicine and Community Health - Institute for Family Health-Harlem Family Medicine Residency, New York.
  • Zhang Y; Reproductive Health and Advocacy Fellowship - Department of Family Medicine - University of Washington, Seattle.
FP Essent ; 538: 13-24, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38498325
ABSTRACT
Short-acting reversible contraceptives (SARCs) are prescribed routinely by primary care clinicians. SARCs are among the most commonly prescribed contraceptive methods and include combined hormonal oral contraceptive pills, the combined hormonal transdermal patch, the combined hormonal vaginal ring, progestin-only pills, and the 3-month depot medroxyprogesterone acetate injection. To ensure safe prescribing and reduce barriers to receiving SARC methods, family physicians should be familiar with two evidence-based national contraceptive guidelines, the U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) and the U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR). SARCs have benefits in addition to pregnancy prevention; as such, these methods may be chosen for reasons other than contraception.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Contraception / Contraceptive Agents Limits: Female / Humans / Pregnancy Language: En Year: 2024 Type: Article
Search on Google
Database: MEDLINE Main subject: Contraception / Contraceptive Agents Limits: Female / Humans / Pregnancy Language: En Year: 2024 Type: Article